# Number of shares and voting rights of Innate Pharma as of April 9, 2026
Canonical URL: https://biopharmsignal.com/news/IPHA/number-of-shares-and-voting-rights-of-innate-pharma-as-of-april-9-2026
Ticker: IPHA
Company: Innate Pharma
Source: Innate Pharma
Published: 2026-04-10 09:11 EST
Original Source URL: https://www.innate-pharma.com
## Summary

<span>Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 9 avril 2026</span> <div class="field field--name-field-date-from field--type-datetime field--label-hidden field--item"><i class="fa fa-clock-o" aria-hidden="true"></i> <time datetime="2026-04-13T05:00:00Z">lun, 04/13/2026 - 07:00</time> </div> <div

## Article Body
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 9 avril 2026

lun, 04/13/2026 - 07:00

Press release in English
                      152.36 Ko
                  
                      
                      Communiqué de presse en français
                      112.16 Ko

helene

ven, 04/10/2026 - 11:15
## Recent Company News
- 2026-07-22 11:17 EST — [Innate Pharma to participate in a bladder cancer panel at the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-a-bladder-cancer-panel-at-the-btig-virtual-biote-960627c0) — Source: Innate Pharma
- 2026-07-20 14:53 EST — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f) — Source: Innate Pharma
- 2026-05-21 17:08 EST — [Outcome of Innate Pharma’s 2026 Annual General Meeting](https://biopharmsignal.com/news/IPHA/outcome-of-innate-pharma-s-2026-annual-general-meeting) — Source: Innate Pharma
- 2026-05-18 11:27 EST — [Innate Pharma to participate in the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-the-jefferies-global-healthcare-conference) — Source: Innate Pharma
- 2026-05-12 13:48 EST — [Innate Pharma Reports First Quarter 2026 Business Update and Financial Results](https://biopharmsignal.com/news/IPHA/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results) — Source: Innate Pharma
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)